DCK and acute lymphoblastic leukemia: As our analyses demonstrated that the DCK gene is critically involved in the antileukemic activity of Ara‐C, and more than half of the cell lines were established from relapsed ALL patients, we speculated that somatic mutations in the coding exons of the DCK gene may be associated with Ara‐C resistance in some BCP‐ALL cell lines.